Category Archives: Hormone Replacement Therapy

Caster Semenya of South Africa celebrates after winning the womens 800m final at the Rio 2016 Olympic Games. Photograph: Diego Azubel/EPA Caster Semenya, the Olympic 800m champion, may be banned from competing at future Games unless she undergoes hormone replacement therapy (HRT) or even surgery in the wake of a landmark study into athletes with raised testosterone levels which has just been published. The International Association of Athletics Federations, the world governing body, commissioned research which has produced the most conclusive evidence yet that female athletes with very high levels of naturally occurring testosterone receive significant performance-enhancing benefits in competition. It comes only weeks before the IAAF is set to challenge a ruling by the court of arbitration for sport which, since 2015, has prevented it from restricting permitted levels of testosterone among female competitors. The new study will not stop Semenya and other hyperandrogenic athletes, such as the Indian sprinter Dutee Chand, from competing at the world championships in London in August but it could have a significant impact on the Cas hearing later this month. It is bound to reopen the controversial and emotionally charged debate around the treatment of female athletes with hyperandrogenism, a medical condition characterised … Continue reading →

CLEVELAND--(BUSINESS WIRE)--Diasome Pharmaceuticals, Inc., an innovative life sciences technology company focused on the development of novel therapies for the treatment of diabetes and other metabolic conditions, announced the agreement today of new funding of up to $30 million led by Medicxi, a leading European life sciences venture capital firm. Diasome is the first investment from Medicxis recently announced Growth Fund I. Other investors in this round include the JDRF T1D Fund (Boston, MA), Black Beret Life Sciences, LLC (Houston, TX), and an investor group led by McDonald Partners, LLC (Cleveland, OH). Diasome's Hepatocyte Directed Vesicles (HDV) technology additive to commercial insulin therapies allows preferential delivery of insulin to the liver's hepatocytes. HDV-insulin is the most clinically advanced novel pre-meal insulin in the global insulin pipeline, and if approved would represent the first insulin therapy specifically designed to mimic the mealtime exposure of the liver to insulin. The investment by Medicxi, JDRF T1D Fund, Black Beret, and McDonald Partners represents a significant validation of Diasomes technology, and we will benefit from their track records of working with and advising successful drug development companies,said Robert Geho, CEO of Diasome. Medicxi founding partner Dr. Michele Ollier said, It has never been understood why … Continue reading →

PAO GROUP INC COM USD0.001 (OTCMKTS:PAOG) is a holding group for what was formerly known as New Wave Holdings. The company is going through a rebranding and in the process of opening up alternative medical centers where medical cannabis is legal. PAOG, formerly NWAV, is a publicly traded holdings company dedicated to the development and launch of PAO Group alternative medicine clinics focused on non-traditional patient care solutions. The realm of treatment solutions include cannabis, acupuncture, chiropractic, biofeedback, and other solutions depending upon patient needs. NWAV recently merged withPAO Group, Inc. (which will trade under PAOG), a physicians practice management company actively developing alternative medicine clinics focused on the proper use of cannabis for treatment of chronic and terminal patients. PAO GROUP INC COM USD0.001 (OTCMKTS:PAOG) has an expansion strategy in mind and it is working to methodically grow. On Jun 26, 2017, PAOG announced the launch of two new Corporate locations for its Alternative Medicine Centers of America. The new locations will open in Toledo and Dayton, Ohio. An in-house psychiatrist will help assist with properly diagnosing PTSD patients at the Dayton location. The Parma and Toledo locations will feature a full suite of therapeutic services as part of … Continue reading →

Yeovil Hospital is to participate in a new clinical trial funded by the charity Breast Cancer Now to investigate the best way to deliver cognitive behavioural therapy (CBT) to reduce the impact of two major side-effects for women undergoing breast cancer treatment. Hot flushes and night sweats are common side effects of current breast cancer treatments such as chemotherapy and anti-hormone drugs. Experienced by up to 70 per cent of women receiving treatment, they can have a huge impact on their daily lives, often affecting employment, personal relationships and general quality of life, and sometimes leading to women not completing the full course of their treatment. Hormone replacement therapy (HRT), which is normally offered to women experiencing hot flushes as part of the menopause, unfortunately cannot be used by women with breast cancer as it can increase the risk of their disease returning. In addition, these side effects can often be more extreme and longer lasting in women who have had breast cancer than those experienced during natural menopause. It is therefore essential that scientists and clinicians find ways to help women undergoing breast cancer treatment reduce the impact of these side effects, to give them the best possible quality … Continue reading →

BBC News Swansea Uni trial to reduce breast cancer hot flushes - BBC News BBC News Scientists will investigate how behavioural therapy could help control difficult side effects. and more » Visit link: Swansea Uni trial to reduce breast cancer hot flushes - BBC News - BBC News … Continue reading →

Hormone replacement therapy is becoming increasingly popular again, but as with any procedure, it does carry some risks. Everyone is different, and individual needs and treatment options can vary from person to person. Patients should, therefore, consult with their doctor in order to weigh options and decide on the right treatment for each individual patient. New research suggests that the older you are, the more you are at risk for hearing loss as a possible side effect of hormone replacement therapy. The potential for the adverse side effect is further increased if you are a woman experiencing menopause and menopausal symptoms. Many women who wish to try hormone replacement therapy do so in order to ease the symptoms of menopause, which can range from mild to devastating. Some people seek out hormone replacement therapy for other reasons, and thats usually okay. You might think that hormone replacement therapy in California is more popular than it is in, perhaps, Idaho, and based on numbers alone you would be right. But proportionally, the number of patients who decide to receive the therapy might not be as skewed toward one region or another as you might think. That is because hormones are no … Continue reading →

Thyroid Hormone Replacement TherapyMarketanalysis is provided for global market including development trends by regions, competitive analysis of Thyroid Hormone Replacement Therapymarket. The Thyroid Hormone Replacement Therapyindustry report firstly announced the Thyroid Hormone Replacement TherapyMarket fundamentals: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Thyroid Hormone Replacement TherapyMarket split by Application Application 1, Application 2, Application 3. Thyroid Hormone Replacement TherapyMarket Segment by Regions (North America, Europe and Asia-Pacific) and the main countries(United States, Germany, United Kingdom, Japan, South Korea and China). Through the statistical analysis,the Thyroid Hormone Replacement TherapyMarket report depicts the global Industry Analysis, Manufacturers Analysis, Thyroid Hormone Replacement TherapyIndustry Development Trend, Sales Demand and Forecast to 2021. Get PDF Sample of Thyroid Hormone Replacement TherapyMarket Report @ https://www.absolutereports.com/enquiry/request-sample/10682271 Table of Contents: Chapter 1: Thyroid Hormone Replacement TherapyMarket Overview 1.1 Definition 1.2 Classification Analysis 1.3 Application Analysis 1.4 Thyroid Hormone Replacement TherapyIndustry Chain Structure Analysis 1.5 Thyroid Hormone Replacement TherapyMarket Development Overview 1.6 Global Thyroid Hormone Replacement TherapyMarket Comparison Analysis 1.6.1 Global Import Market Analysis 1.6.2 Global Export Market Analysis 1.6.3 Global Main Region Market Analysis 1.6.4 Global Market Comparison Analysis 1.6.5 Global Market Development Trend Analysis Chapter 2:Thyroid Hormone … Continue reading →

Hormone Replacement TherapyMarketanalysis is provided for global market including development trends by regions, competitive analysis of Hormone Replacement Therapymarket. The Hormone Replacement Therapyindustry report firstly announced the Hormone Replacement TherapyMarket fundamentals: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Hormone Replacement TherapyMarket split by Application Application 1, Application 2, Application 3. Hormone Replacement TherapyMarket Segment by Regions (North America, Europe and Asia-Pacific) and the main countries(United States, Germany, United Kingdom, Japan, South Korea and China). Through the statistical analysis,the Hormone Replacement TherapyMarket report depicts the global Industry Analysis, Manufacturers Analysis, Hormone Replacement TherapyIndustry Development Trend, Sales Demand and Forecast to 2021. Get PDF Sample of Hormone Replacement TherapyMarket Report @ https://www.absolutereports.com/enquiry/request-sample/10682272 Table of Contents: Chapter 1: Hormone Replacement TherapyMarket Overview 1.1 Definition 1.2 Classification Analysis 1.3 Application Analysis 1.4 Hormone Replacement TherapyIndustry Chain Structure Analysis 1.5 Hormone Replacement TherapyMarket Development Overview 1.6 Global Hormone Replacement TherapyMarket Comparison Analysis 1.6.1 Global Import Market Analysis 1.6.2 Global Export Market Analysis 1.6.3 Global Main Region Market Analysis 1.6.4 Global Market Comparison Analysis 1.6.5 Global Market Development Trend Analysis Chapter 2:Hormone Replacement TherapyUp and Down Stream Industry Analysis 2.1 Upstream Raw Materials Analysis of Hormone … Continue reading →

A former Major League Baseball trainer is fairly certain that ballplayers are using steroids again. Thats if they ever really stopped, the trainer, who worked for more than 10 seasons with a big league ballclub, recently told me. It wouldnt surprise me. Established guys like Toronto Blue Jays first baseman Justin Smoak protest otherwise. People wouldnt feel that way if they knew how often we are tested, Smoak told me last week. Weve had blood drawn already this season and urinalysis, too. I dont know how many times already, but its a lot. As players, it is something we fought for to get the bad stuff out of the game. Just because we dont have a Mark McGwire vs. Sammy Sosa home run chase that is sponsored by MLB and fueled by a syringe doesnt mean we are not witnessing another historic home run pursuit in 2017. Theyve moved the fences in, Rangers manager Jeff Banister said last week. San Diego, Detroit, Houston ... I dont have any earth-shattering theories. I just think we are ahead of the pace this year than years past. Yeah ... no. Im not buying its the ball, either. I know people say its the … Continue reading →

Osteoarthritis a disease of joints is reported more among women than men. According to experts, fluid in the knee holds clues why women are more prone to it. They have found in the synovial fluid of this joint, clear differences in the messages cells are sending and receiving via tiny pieces of RNA, called microRNA, in males and females with the common and debilitating condition osteoarthritis. The differences may help explain why the disease is more common in women as it points toward a more targeted way to diagnose and treat this wear and tear arthritis, said Dr. Sadanand Fulzele, bone biologist in the Department of Orthopaedic Surgery at the Medical College of Georgia at Augusta University. Osteoarthritis, which affects more than 30 million Americans, is fundamentally a destruction of the cartilage that provides padding between our bones. In the past, obesity has also been considered a factor. Its a huge problem, says Dr. Monte Hunter, chair of the MCG Department of Orthopaedic Surgery and a co-author of the study in the journal Scientific Reports. Todays treatment addresses symptoms, like inflammation and pain, and the bottom line for some patients is knee replacement. Synovial fluid is known to provide clues … Continue reading →